Immunotherapy shows promise against melanoma

June 2, 2014 6:13 PM

6 0

By unleashing the immune system to attack skin cancer, researchers have made important strides against melanoma, according to the results of three clinical trials released Monday.

The first study presented at the American Society of Clinical Oncology annual meeting showed patients given a drug called Yervoy (ipilimumab), made by Bristol Myers-Squibb, saw a 25 percent reduced risk of the cancer coming back when compared to a placebo.

Also watch: Monkeys Can Make Stone Tools, but They Don’t Use Them

Read more

To category page